Vanguard Investments Australia »

Silverback Therapeutics shares owned by Vanguard Investments Australia

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Vanguard Investments Australia from 13F filings

Historical chart of Vanguard Investments Australia investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Vanguard Investments Australia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Vanguard Investments Australia

Quarter filed Position value Share count Share price at filing
2026-03-31 $85k 11k 8.03